The modern version of RSI starts with preoxygenation. General anaesthesia is then induced using a rapid acting intravenous anaesthetic and a rapid acing muscle relaxant. Cricoid pressure is applied by an experienced assistant during induction, which should then be maintained until the trachea of the patient is intubated, correct positioning of the tracheal tube confirmed and the cuff inflated. The patient is conventionally not ventilated during this phase but critically ill patients are exceptions. The patient's tracheal should be intubated when adequately paralysed and its position verified. The assistant can then relieve the cricoid pressure and the tracheal tube fixed.
Introduction
One year after the demonstration of general anaesthesia by William Morton using ether, Sir James Young Simpson introduced chloroform into clinical practice. He also reported the first anaesthetic death the next year. 1 A girl named Hannah Greener became pale after induction of anaesthesia for the removal of ingrowing toenail. This was most likely due to development of arrhythmia: a common complication of chloroform. The treatment then was to administer brandy by mouth. The patient subsequently vomited, aspirated and died. Despite this report, the issue of pulmonary aspiration of gastric content was neglected for a whole century until Curtis Mendelson reported a series of pregnant women who aspirated during l a b o u r i n 1 9 4 6 .
2 T h i s p h e n o m e n o n wa s subsequently called the "Mendelson syndrome" and it aroused the interest of anaesthesiologists. Early forms of rapid sequence induction and intubation (RSI) was described in the early 1950's. 3 The technique was subsequently modified and the most noticeable being the introduction of cricoid pressure by Barry Sellick in 1961. 4 
Preoxygenation
The moder n technique of RSI star ts with preoygenation of the patient. The purpose of prexoygenation is to replace nitrogen in the functional residual capacity (FRC) of the patient's lung with oxygen. This will then increase the patient's reserve of oxygen during the period of apnoea (vide infra). The rate of change of oxygen content in the FRC during preoxygenation follows that of a wash-in exponential function with its time constant (l) equal to FRC divided by alveolar ventilation (V A ) (l=FRC/V A ). Given that the usual FRC is around 40 ml/kg and alveolar ventilation (minute ventilation minus deadspace ventilation) around 50 ml/kg/min, l would be around 0.8 min. At the end of 4 time constant (or around 3 minutes for preoxygenation when the patient breathes normally) 98% of the exponential process will be completed. Therefore, the usually recommended time required for preoxygenation is around 3 minutes. It will, of course, be modified by changes in functional residual capacity and/or alveolar ventilation of the patient.
An alternative technique is to ask the patient to take 4 maximal (vital capacity) breaths. 5, 6 This technique allows preoxygenation to be completed within a shorter period of time. To use this technique one must use a reservoir bag big enough to accommodate the patient's vital capacity. This technique has been found to be less effective especially in elderly patients. 7, 8 It is important to ensure that the mask is placed properly on the patient to avoid leakage during the whole process of preoxygenation. This is especially true in patients with reduced FRC, for example due to obesity, pregnancy or diseases causing abdominal distension, whose oxygen reserve are reduced despite preoxygenation.
Intravenous anaesthetic agents used in RSI
Thiopentone is the first clinically useful intravenous anaesthetic agent and a classic drug for RSI in operating suites. Its short duration of action is not due to rapid elimination but because of the phenomenon of redistribution. Repeated doses will therefore lead to accumulation and prolonged action. It is useful for those patients with headinjur y but remain haemodynamically stable. Thiopentone is also a potent anticonvulsant. It is, however, contraindicated in patients who are haemodynamically unstable due to hypovolaemia or other reasons. The usual dose is 2-5 mg/kg and should be adjusted according to the patient's condition.
Propofol (Diprivan
Propofol is a hintered phenol which is rapidly metabolised by the body. Its advantages over thiopentone include rapid recovery even on repeated doses, and less emetic. The drug may produce euphoria and therefore has been abused. It may also cause pain on injection. Propofol can also result in arterial hypotension and is contraindicated in haemodynamically unstable patients. Despite its efficacy in RSI 9 propofol has no advantage in emergency settings outside the operating suite. The usual dose is 1-2.5 mg/kg via the intravenous route.
Etomidate (Lipuro â â â â â ) Etomidate 10 is an imidazole compound which is rapidly metabolised. The drug may cause pain on injection, vomiting and excitatory phenomena on induction. It also inhibits steroidogenesis by inhibiting the enzyme 11b-hydroxylase and is banned for use as infusion. However, the drug may be a good choice in emergency settings due to its relatively less depressive effect on the cardiovascular system. The usual dose is 0.2-0.6 mg/kg via the intravenous route.
Ketamine (Ketalar
Being an analog of phencyclidine, ketamine 11 is associated with emergence phenomenon. It can cause hypertension and tachycardia. While this can be an advantage for patients who are hypotensive, ketamine may occasionally cause more hypotension when administered to patients in shock. Ketamine is a bronchodilator and is usually chosen for anaesthetizing patients in asthmatic attack when they require intubation. It is also a good analgesic. The usual dose is 0.5-2.0 mg/kg intravenously or 4-6 mg/kg intramuscularly.
Midazolam (Dormicum
The benzodiazepine midazolam is not usually used for RSI in the operating room due to its relatively slow onset of action and also because it is less reliable as an induction agent when compared with other intravenous anaesthetics. 12 Although it may lead to delay in intubation, it has been used for RSI 13 and is especially useful if haemodynamic stability is an important concern. Usual dose of 0.1-0.2 mg/kg iv but use small aliquots of 1-2 mg and titrate to effect in unstable patients.
N e u ro m u s c u l a r b l o c ke r s ( m u s c l e relaxants) used in RSI
Suxamethonium is the most commonly used muscle relaxant during RSI, but non-depoloarizers may have to be used when the for mer is contraindicated.
Suxamethonium
Its rapid onset, short duration of action as well as g ood quality of muscle relaxation makes sumethonium 14 the ideal muscle relaxant for RSI. The usual dose in 1.0-1.5 mg/kg. However, suxamethonium may cause many side effects and these may limit its usefulness.
Arrhythmias. Suxamethonium may cause sinus bradycardia, junctional rhythms or even asystole. These usually occur when a second dose is required as the effect of the first dose wear off. It is more common in children and it may occur even when the first dose is given to children. It is therefore important to have atropine ready whenever suxamethonium is given. Suxamethonium can also lower the threshold of myocardium to catecholamine-induced arrhythmias. 15, 16 Hyperkalaemia. Administration of suxamethonium will normally result in raising the serum potassium by about 0.5 mmol/L. 17 However, in some patients the increase in serum potassium associated with suxamethonium can be lethal. For patients with severe burns, it is safe to administer suxamethonium within the first 24-48 hours. The duration of susceptibility is unknown but may last for 1-2 years after burned skin healed. For patients with major trauma, suxamethonium is safe for the first 2-3 days. The patient is then susceptible to hyperkalaemia until there is adequate healing of damaged muscle. Patients suffering from congenital/hereditary muscle disease, spinal cord injury, peripheral nerve injury, or tetanus may be susceptible to hyperkalaemia when given suxamethonium for a variable period. 17, 18 The possibility of hyperkalaemia after suxamethonium should be considered in patients with intra-abdominal infections that persisted for over 1 week. 19 Despite one case report of hyperkalaemia associated with closed head injury, 20 the latter is not usually considered a high risk condition. Patients with renal failure had not been proven to be more susceptible to hyperkalaemia except in those with uraemic neuropathy. 21, 22 Increased intraocular pressure. This effect can be important in patients with open-eye injuries as it may result in loss of intraocular content through t h e o p e n w o u n d . T h e c h o i c e b e t w e e n suxamethonium or non-depolarizer is one between mild increase in IOP versus a longer time interval required for intubation. 23 Suxamethonium with pre-treatment (vide infra) is an acceptable technique for anaesthetising patients with open eye injury 24 but high dose rocuronium can also be used as an alternative. 25, 26 Increased intracranial pressure. Suxamethonium had been shown to increase intracranial pressure in dogs 27 but clinical trial in patients with severe head injury found no significant change in intracranial pressure after administration of suxamethonium. 28 It is considered safe to administer suxamethonium in most neurosurgical patients 29 especially after smooth thiopentone-hyperventilation sequence. Some experienced anaesthesiologist may use an alternative technique when hyperventilation or thiopentone cannot be used 30 31 However, this may not apply in patients with hiatus hernia, parturients or obese patients. 32 These side effects may be minimised by self-taming or pre-treatment. Self-taming means giving a small dose (10 mg) of suxamethonium before administration of the main dose. 33 The technique is currently not commonly practiced as it may not always be effective. 34 Pre-treatment, on the other hand, is practiced fairly commonly and consist of giving a small dose (about 10% intubating dose) of a non-depolarizing neuromuscular blocker 60 seconds before giving suxamethonium. 35 Use of suxamethonium paediatric patients is currently only indicated for emergency intubation. 36, 37 This is due to reports of hyperkalaemia, rhabdomyolysis and acidosis after administration of suxamethonium to apparently healthy children who may actually be suffering from unsuspected muscle dystrophy.
38,39
Non-depolaring neuromuscular blockers It may be necessary to administer a drug of this group when suxamethonium is contraindicated. Problems associated with these drugs include haemodynamic effect (usually hypotension), histamine release and accumulation in those patients with impaired renal and/or liver function. These are less of an issue amongst modern non-depolarizers such as rocuronium (Esmeron â â â â â , usual intubating dose 0.6 mg/kg) or cis-atracurium (Nimbex â â â â â , usual intubating dose 0.16 mg/kg). The problem of delayed onset may be partially overcome by either using the priming technique or mega-dosing. In the priming technique, a small (10% intubating dose) dose of non-depolarizer is given 4-6 minutes before the main dose. [40] [41] [42] [43] The technique, however, should be used with caution as the priming dose itself may cause muscle weakness, resulting in depressed swallowing 44 and decrease in oxygen saturation in the elderly. 45 In mega-dosing, a dose higher than the usual intubating dose is used. Some of those which has been tried include rocuronium 1 mg/kg, 46 mivacurium 0.15 mg/kg followed 30 seconds later by 0.1 mg/kg, 47 or vecuronium 0.3 mg/kg. 48 
Cricoid pressure
After its introduction by Barry Sellick in 1961, 4 cricoid pressure has become the technique of choice to prevent regurgitation and has replaced earlier methods such as putting the patient 40 o head up. 49 The exact technique of cricoid pressure, however, has undergone many modifications. The initial recommendation of Sellick is to place the neck in full extension, 4 and then later on he recommended slight extension of the neck. 49 It is now believed that it is effective in the sniffing position. 50 The cricoid cartilage, which is caudal to the more prominent thyroid cartilage, should be identified before induction of anaesthesia. The assistant should then fix the cricoid cartilage using his thumb and middle finger while pressing directly backwards using his index finger. While application of pressure should start with injection of anaesthetic, full pressure, which is usually quoted to be 44 N 51 should only be applied when the patient is anaesthetized. The pr e s s u r e s h o u l d b e m a i n t a i n e d u n t i l t h e laryngoscopist is satisfied that the tube is in the trachea (vide infra) and the cuff is inflated. There are different methods to train the assistant to apply the correct pressure: including that this is the pressure required to prevent swallowing of fluids, to deform the spine or even by using a specially designed instrument called the cricoid yoke. 52 More recently, it is found that a force of 44 N may obliterate the cricoid ring and result in difficulty in ventilating and/or intubating the patient. 53 The assistant should be instructed to reduce the applied pressure when it is difficult to ventilate or intubate the patient. The bimanual method was described by Crowley & Giesecke with the assumption that less distortion of the neck may make visualization of the vocal cord and intubation easier. 54 However, the technique has not been found to be consistent in improving vocal cord visualization 55, 56 and is not applicable for patients with proven or suspected cervical spine injury. 57 It is also possible to combine cricoid pressure together with optimal external laryngeal manipulation. 58, 59 Cricoid pressure is effective in sealing the oesophagus around the nasogastric tube 60, 61 and it is not necessary to remove any inserted nasogastric tube before RSI. The nasogastric tube should not be blocked as the unoccluded tube can then act as a "blow-off" valve to relieve any pressure built up in the stomach. 61 While cricoid pressure is contraindicated in the presence of suspected airway injury, vomiting, foreign body in the oesophagus or airway, retropharyngeal abscess, severe cervical arthritis or upper oesophagus pouch; it is considered safe in patients with suspected or proven cervical spine injury. 62, 63 Should the patient be ventilated while waiting for muscle relaxant to take effect?
The conventional teaching has been that the patient should not be ventilated manually to avoid gastric inflation. 64 Gastric inflation was found to be unlikely if the peak airway pressure is less than 20 cmH 2 O in patients who are not paralysed and in the absence of cricoid pressure. 65 When the patient is paralysed gastric inflation may occur at a lower peak airway pressure. This may be the result of paralysis of the cricopharyngeus muscle and/or increase abdominal compliance. 66 However, it has been demonstrated repeatedly that ventilation after application of cricoid pressure is safe provided the airways are patent. [66] [67] [68] [69] More and more anaesthesiologist would manually ventilate the patient before intubation especially in the emergency setting when the patient's lung and oxygenation may not be normal.
Tracheal intubation
The usual technique recommended is one using direct laryngoscopy. The MacInstosh laryngoscope and a PVC tracheal tube of the Murphy's type is usually used. Putting the patient into a sniffing position (flexion of neck and extension at the atlanto-occipital joint) will facilitate intubation, and when this is contraindicated as in the case of suspected/proven cervical spinal injury, intubation is more difficult. Such intubation should as far as possible be perfor med by an experienced laryngoscopist. Intubation is also facilitated by using a stylet and sometimes by application of optimal external laryngeal manipulation (OELM). This author would recommend using a stylet as a routine in the emergency setting as it could save precious time. OELM is useful if the patient's larynx is anterior. 59 The laryngoscopist should guide the finger of the assistant to apply pressure on the thyroid until the best view is obtained.
Verification of tube position
It is essential to make sure that (1) the tube is in the trachea and not in the oesophagus; and (2) the tube is not down one of the main bronchus immediately after intubation.
While many methods have been described to verify that the tube is in the trachea, most of them are not failsafe. 70 (Table 1 ) There are only 2 methods which are failsafe: direct visualization of the tube between cords 71 or use of fibreoptic bronchsocpes. The former may not always be possible and the latter is often impractical. There are 2 almost failsafe methods: identification of carbon dioxide in exhaled gas using capnometer of the spectrophotometric type or the simpler calorimetric type; 72 or using the oesophageal detector device. 73 This author would recommend ensuring availability of equipment required for at least one if not both techniques be available in locations where tracheal intubation are performed.
Auscultation over both axillae is the usual method to detect or exclude endobronchial intubation. The pitfall of this method in the emergency setting is that the patient may have significant pathology in one side of the lung to account for the difference in breath sounds. It is therefore always desirable to insert the tube under direct visualization and stop when the upper border of the cuff is 1-2 cm below the vocal cord. Chest x-ray will also be useful but takes time.
Hazards
A patient will become hypoxaemic rapidly and die if they are paralysed but cannot be intubated or ventilated. RSI is therefore not recommended for inexperienced personnel. The patient should be ventilated by mask, using both hands and with the aid or orophar yngeal airways if necessary, if intubation is not possible. There should be a backup plan in case the patient cannot be intubated and cannot be ventilated. 74 Anaesthetic drugs can cause side effects such as haemodynamic instability and one must familiarize himself/herself with those drugs before administering them to patients.
